Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1982 Feb;75(2):325–331. doi: 10.1111/j.1476-5381.1982.tb08790.x

Relationship between lesion formation and permeability of rat gastric mucosa to H+ and other cations.

K T Bunce, J J McCarthy, C F Spraggs, R Stables
PMCID: PMC2071600  PMID: 6964662

Abstract

The relationship between lesion formation and ionic permeability has been investigated in rat gastric mucosa in vivo. Changes in these parameters were measured in the mucosa treated topically with prostaglandins E2 and A2 and/or aspirin. Particular attention was paid to the net flux of H+ ions across the gastric mucosa. The effect of aspirin concentrations of 5 mM, 20 mM and '40 mM' (the latter, a suspension in a saturated solution) was investigated. Aspirin concentrations of 20 mM and '40 mM' produced a marked increase in lesion formation and increased the net mucosal to serosal flux of H+ ions. Aspirin 5 mM produced a significant increase in lesion formation but did not cause a significant change in net H+ ion flux. This result suggests that aspirin can have a direct irritant effect on the gastric mucosa and that the back diffusion of H+ ions is not a pre-requisite for the development of overt mucosal ulceration. The effect of topically applied prostaglandin E2 (PGE2) on aspirin-induced gastric mucosal damage was investigated. Concentrations of PGE2 of 10(-5) M and 10(-4) M ameliorated aspirin-induced damage, but these changes were not necessarily accompanied by a significant reduction in net H+ ion flux. Again, this result is not consistent with a direct relationship between lesion formation and mucosal permeability to H+ ions. Since PGA2 did not ameliorate aspirin-induced mucosal damage, the protective effect of PGE2 could not be attributed to its conversion to PGA2 in the acidic environment of the gastric lumen.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
325

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen A., Garner A. Mucus and bicarbonate secretion in the stomach and their possible role in mucosal protection. Gut. 1980 Mar;21(3):249–262. doi: 10.1136/gut.21.3.249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bolton J. P., Cohen M. M. Effect of 16,16-dimethyl prostaglandin E2 on the gastric mucosal barrier. Gut. 1979 Jun;20(6):513–517. doi: 10.1136/gut.20.6.513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bolton J. P., Palmer D., Cohen M. M. Stimulation of mucus and nonparietal cell secretion by the E2 prostaglandins. Am J Dig Dis. 1978 Apr;23(4):359–364. doi: 10.1007/BF01072421. [DOI] [PubMed] [Google Scholar]
  4. Bommelaer G., Guth P. H. Protection by histamine receptor antagonists and prostaglandin against gastric mucosal barrier disruption in the rat. Gastroenterology. 1979 Aug;77(2):303–308. [PubMed] [Google Scholar]
  5. Bugat R., Thompson M. R., Aures D., Grossman M. I. Gastric mucosal lesions produced by intravenous infusion of aspirin in cats. Gastroenterology. 1976 Nov;71(5):754–759. [PubMed] [Google Scholar]
  6. Cheung L. Y. Topical effects of 16,16-dimethyl prostaglandin E2 on gastric blood flow in dogs. Am J Physiol. 1980 Jun;238(6):G514–G519. doi: 10.1152/ajpgi.1980.238.6.G514. [DOI] [PubMed] [Google Scholar]
  7. Cooke A. R. The role of acid in the pathogenesis of aspirin-induced gastrointestinal erosions and hemorrhage. Am J Dig Dis. 1973 Mar;18(3):225–237. doi: 10.1007/BF01071977. [DOI] [PubMed] [Google Scholar]
  8. Davenport H. W. Potassium fluxes across the resting and stimulated gastric mucosa: injury by salicylic and acetic acids. Gastroenterology. 1965 Sep;49(3):238–245. [PubMed] [Google Scholar]
  9. Davenport H. W. Salicylate damage to the gastric mucosal barrier. N Engl J Med. 1967 Jun 8;276(23):1307–1312. doi: 10.1056/NEJM196706082762308. [DOI] [PubMed] [Google Scholar]
  10. Fromm D. Gastric mucosal "barrier". Gastroenterology. 1979 Aug;77(2):396–398. [PubMed] [Google Scholar]
  11. Fromm D. Salicylate and gastric mucosal damage. Pediatrics. 1978 Nov;62(5 Pt 2 Suppl):938–942. [PubMed] [Google Scholar]
  12. Ivey K. J. Gastric mucosal barrier. Gastroenterology. 1971 Aug;61(2):247–257. [PubMed] [Google Scholar]
  13. Kauffman G. L., Jr, Reeve J. J., Jr, Grossman M. I. Gastric bicarbonate secretion: effect of topical and intravenous 16,16-dimethyl prostaglandin E2. Am J Physiol. 1980 Jul;239(1):G44–G48. doi: 10.1152/ajpgi.1980.239.1.G44. [DOI] [PubMed] [Google Scholar]
  14. Konturek S. J., Piastucki I., Brzozowski T., Radecki T., Dembińska-Kieć A., Zmuda A., Gryglewski R. Role of prostaglandins in the formation of aspirin-induced gastric ulcers. Gastroenterology. 1981 Jan;80(1):4–9. [PubMed] [Google Scholar]
  15. Miller T. A., Tepperman B. L. Effect of prostaglandin E2 on aspirin-induced gastric mucosal injury. J Surg Res. 1979 Jan;26(1):10–17. doi: 10.1016/0022-4804(79)90072-6. [DOI] [PubMed] [Google Scholar]
  16. Puurunen J. Effect of prostaglandin E2, cimetidine, and atropine on ethanol-induced gastric mucosal damage in the rat. Scand J Gastroenterol. 1980;15(4):485–488. doi: 10.3109/00365528009181505. [DOI] [PubMed] [Google Scholar]
  17. Rainsford K. D. Gastrointestinal and other side-effects from the use of aspirin and related drugs; biochemical studies on the mechanisms of gastrotoxicity. Agents Actions Suppl. 1977;(1):59–70. [PubMed] [Google Scholar]
  18. Rainsford K. D., Whitehouse M. W. Biochemical gastroprotection from acute ulceration induced by aspirin and related drugs. Biochem Pharmacol. 1980 May 1;29(9):1281–1289. doi: 10.1016/0006-2952(80)90286-5. [DOI] [PubMed] [Google Scholar]
  19. Tarnawski A., Ivey K. J. Effect of pentagastrin on potential difference in rat stomach. Proc Soc Exp Biol Med. 1980 Jan;163(1):162–166. doi: 10.3181/00379727-163-40740. [DOI] [PubMed] [Google Scholar]
  20. Thjodleifsson B., Wormsley K. G. Back-diffusion--fact or fiction? Digestion. 1977;15(1):53–72. doi: 10.1159/000197983. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES